[go: up one dir, main page]

WO2006005940A3 - Monoclonal anti-glut2 antibody - Google Patents

Monoclonal anti-glut2 antibody Download PDF

Info

Publication number
WO2006005940A3
WO2006005940A3 PCT/GB2005/002727 GB2005002727W WO2006005940A3 WO 2006005940 A3 WO2006005940 A3 WO 2006005940A3 GB 2005002727 W GB2005002727 W GB 2005002727W WO 2006005940 A3 WO2006005940 A3 WO 2006005940A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibody
monoclonal anti
glut2
glut2 antibody
recognises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2005/002727
Other languages
French (fr)
Other versions
WO2006005940A2 (en
Inventor
Peter Collins
Archie Roberston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIVERSIDE BIOSCIENCES Ltd
Original Assignee
RIVERSIDE BIOSCIENCES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIVERSIDE BIOSCIENCES Ltd filed Critical RIVERSIDE BIOSCIENCES Ltd
Publication of WO2006005940A2 publication Critical patent/WO2006005940A2/en
Publication of WO2006005940A3 publication Critical patent/WO2006005940A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A monoclonal antibody that recognises glucose transporter 2 (GLUT2) is described, as well as a hybridoma that produces the antibody. The antibody may be used to identify or isolate embryonic or fetal cells, for example in an in vitro method of prenatal diagnosis.
PCT/GB2005/002727 2004-07-13 2005-07-13 Monoclonal anti-glut2 antibody Ceased WO2006005940A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0415644A GB0415644D0 (en) 2004-07-13 2004-07-13 Monoclonal antibody
GB0415644.4 2004-07-13

Publications (2)

Publication Number Publication Date
WO2006005940A2 WO2006005940A2 (en) 2006-01-19
WO2006005940A3 true WO2006005940A3 (en) 2006-04-27

Family

ID=32893490

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/002727 Ceased WO2006005940A2 (en) 2004-07-13 2005-07-13 Monoclonal anti-glut2 antibody

Country Status (2)

Country Link
GB (1) GB0415644D0 (en)
WO (1) WO2006005940A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2215474A4 (en) * 2007-07-16 2012-07-18 Avaxia Biologics Inc Antibody therapy for modulating function of intestinal receptors
EP2244735A4 (en) 2007-10-02 2011-02-23 Avaxia Biologics Inc Antibody therapy for use in the digestive tract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040746A1 (en) * 1997-03-08 1998-09-17 The University Of Dundee Prenatal diagnostic methods
WO2002021132A2 (en) * 2000-09-08 2002-03-14 University Of Dundee Cell assays

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040746A1 (en) * 1997-03-08 1998-09-17 The University Of Dundee Prenatal diagnostic methods
US6331395B1 (en) * 1997-03-08 2001-12-18 The University Of Dundee Prenatal diagnostic methods
WO2002021132A2 (en) * 2000-09-08 2002-03-14 University Of Dundee Cell assays

Also Published As

Publication number Publication date
WO2006005940A2 (en) 2006-01-19
GB0415644D0 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
WO2005100401A3 (en) Monoclonal antibodies with specificity for fetal erythroid cells
WO2007035633A3 (en) Screening assays and methods
PT1415158E (en) METHOD FOR SELECTING CELLS EXPRESSING ANTIBODIES
WO2006094192A3 (en) Humanized l243 antibodies
WO2019008123A3 (en) Cells, vertebrates, populations & methods
WO2007095506A8 (en) Oligosaccharide modification and labeling of proteins
WO2001098358A3 (en) Compositions for identification and isolation of stem cells
WO2007079183A3 (en) Placental stem cell populations
WO2007110678A3 (en) Neutralizing antibodies and methods of use thereof
DE60238308D1 (en) QUICK PRODUCTION MONOCLONAL ANTIBODY
WO2003002972A3 (en) Method and device for obtaining a sample with three-dimensional microscopy
WO2006127517A3 (en) Pretreatment of a biological sample from an autoimmune disease subject
WO2006083782A3 (en) Directed differentiation of embryonic stem cells and uses thereof
ATE486610T1 (en) ANTI-GLYPICAN-3 ANTIBODIES
WO2008002712A3 (en) Systems and methods for integrating outsourcers
WO2011002727A9 (en) Methods of producing humanized non-human mammals
TW200700092A (en) Tigecycline compositions and methods of preparation
ATE462012T1 (en) EZYMATIC PROCESS FOR PRODUCING 2-O-GLYCERYL-ALPHA-D-GLUCOPYRANOSIDE
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
WO2006113881A3 (en) Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
WO2002010337A3 (en) Method of cloning porcine animals
WO2015035239A3 (en) Reagents and methods for screening mps i, ii, iiia, iiib, iva, vi, and vii
WO2006133356A3 (en) Elimination of n-glycolylneuraminic acid from mammalian products for human use
WO2006116181A3 (en) Regulatory t cell mediator proteins and uses thereof
WO2007027805A3 (en) Method for generating anti-variable region monoclonal antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase